(MedPage Today) -- In another edition of the Slippery Slope series examining use of surrogate endpoints in drug approvals, MedPage Today and the Milwaukee Journal Sentinel find diet drugs are approved without solid evidence of benefits, but with hints of harm.
No comments:
Post a Comment